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Hydrodynamics of the VanA-type 
VanS histidine kinase: an extended 
solution conformation and first 
evidence for interactions with 
vancomycin
Mary K. Phillips-Jones1, Guy Channell2, Claire J. Kelsall1, Charlotte S. Hughes1,3, 
Alison E. Ashcroft4, Simon G. Patching4, Vlad Dinu2, Richard B. Gillis2,5, Gary G. Adams2,5 & 
Stephen E. Harding2
VanA-type resistance to glycopeptide antibiotics in clinical enterococci is regulated by the VanSARA two-
component signal transduction system. The nature of the molecular ligand that is recognised by the 
VanSA sensory component has not hitherto been identified. Here we employ purified, intact and active 
VanSA membrane protein (henceforth referred to as VanS) in analytical ultracentrifugation experiments 
to study VanS oligomeric state and conformation in the absence and presence of vancomycin. A 
combination of sedimentation velocity and sedimentation equilibrium in the analytical ultracentrifuge 
(SEDFIT, SEDFIT-MSTAR and MULTISIG analysis) showed that VanS in the absence of the ligand is 
almost entirely monomeric (molar mass M = 45.7 kDa) in dilute aqueous solution with a trace amount 
of high molar mass material (M ~ 200 kDa). The sedimentation coefficient s suggests the monomer 
adopts an extended conformation in aqueous solution with an equivalent aspect ratio of ~(12 ± 2). 
In the presence of vancomycin over a 33% increase in the sedimentation coefficient is observed with 
the appearance of additional higher s components, demonstrating an interaction, an observation 
consistent with our circular dichroism measurements. The two possible causes of this increase in s – 
either a ligand induced dimerization and/or compaction of the monomer are considered.
Vancomycin is a tricyclic glycopeptide used to treat penicillin-resistant infections caused by Gram-positive bac-
teria including bloodstream infections and infective endocarditis of enterococcal origin and meningitis caused by 
methicillin-resistant Staphylococcus aureus1,2. Vancomycin and related glycopeptide antibiotics inhibit the final 
steps of bacterial cell wall biosynthesis by binding to the C-terminal D-Ala–D-Ala peptide of the muramyl pen-
tapeptide of peptidoglycan precursor Lipid II3–10. Surface plasmon resonance and other studies revealed values 
for the equilibrium dissociation constants (Kd) for vancomycin binding of 1.32 μ M11, 2.7 μ M12 and 3.39 μ M13, 
indicative of moderate binding. Glycopeptide binding results in inhibition of transpeptidase and transglycosylase 
activities, affecting the crosslinking process in growing peptidoglycan, formation of glycan chains and incorpora-
tion of peptidoglycan precursors leading to osmotic shock and cell lysis14–16.
Resistance to glycopeptide antibiotics amongst pathogenic bacteria has emerged and spread across the world 
at a rapid rate17,18. Of the six types of acquired resistance found in Gram-positive bacteria, the VanA type is the 
most common amongst clinical enterococci and the first to have spread to staphylococci19. Inducible resistance to 
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high levels of vancomycin and teicoplanin (the VanA phenotype) in enterococci occurs as a result of acquisition of 
genes that encode enzymes that (1) synthesise an alternative target peptidoglycan precursor D-Ala-D-Lac which 
lacks one of the hydrogen bonding sites involved in glycopeptide binding, thereby constituting a low-affinity pre-
cursor that exhibits an approximately 1000-fold reduced affinity for the antibiotic; and (2) eliminate pre-existing 
high-affinity D-Ala-D-Ala precursors thereby removing the glycopeptide-binding target20,21. The genes encod-
ing these enzymes are regulated by the VanSR two-component signal transduction system22,23. VanS is the 
membrane-bound sensor kinase component involved in inducer sensing and VanR is the partner response regu-
lator component responsible for activating resistance gene expression. In vitro experiments with cytosolic VanS 
of A-type resistance demonstrated both autophosphorylation activity and phosphotransfer activity to VanR24. 
VanR~P increases transcription of the PR promoter involved in VanS/VanR expression thereby increasing its own 
synthesis, and the PII promoter for the vanHAX resistance operon expression25. VanR~P is still generated in the 
absence of VanS due to the activities of acetyl phosphate and/or cross-talking histidine kinase phosphodonors 
resulting in constitutive activation of the PR and PII promoters25. It was suggested therefore that in the absence of 
glycopeptides, VanS acts as a negative regulator of VanR, removing phosphate from VanR through its phosphatase 
activity and thus preventing any significant resistance gene expression in the absence of inducer. In the presence 
of inducer, VanS switches from phosphatase to kinase mode, resulting in higher levels of VanR~P and induction 
of the vanHAX resistance genes. The nature of the activating inducer in VanA-type resistance remains unknown. 
Studies of distantly-related VanS sensors in streptomycetes and enterococci (VanB-type) have provided evidence 
that the antibiotic itself or the antibiotic bound to the D-Ala-D-Ala substrate serve as the inducing effectors whilst 
in VanA-type resistances it has been speculated that the inducer might be a peptidoglycan precursor26–28. Here 
we provide direct in vitro evidence that vancomycin binds to the purified A-type VanS and causes changes to the 
state of the sensor. The study employs an in vitro approach developed previously in our laboratory for the rou-
tine production of purified intact and active membrane sensor kinases of bacteria including the enterococci29,30. 
Heterologously-expressed, His6-tagged VanS was purified as an intact membrane protein and verified as intact by 
mass spectrometry, N-terminal sequencing and Western blotting. In common with most purified intact sensor 
kinases, it was active in the absence of ligand as revealed using in vitro autophosphorylation activity assays30. We 
consider the oligomeric state in aqueous solution (supplemented with 20% glycerol to ensure the protein remains 
stable and active) using sedimentation velocity (SEDFIT analysis, ref. 31) in the analytical ultracentrifuge supple-
mented by sedimentation equilibrium measurements, and the routines SEDFIT-MSTAR32 and MULTISIG33. The 
solution conformation of the VanS was then analysed using the ELLIPS suite of conformation algorithms34 and 
the effect of the addition of vancomycin was explored.
Results
Expression, verification and characterisation of purified active intact VanS. Expression of 
the majority of membrane proteins is generally expected to be significantly lower than that of soluble proteins 
and purification more technically challenging due to the hydrophobicity of membrane proteins. To determine 
whether VanS was successfully expressed in E. coli BL21 [DE3], water lysis preparations of cultures induced or 
uninduced with 1 mM isopropyl β -D-1-thiogalactopyranoside (IPTG) were prepared as described in Methods. 
Fig. 1A,B summarises expression in E. coli mixed membranes and clearly shows the presence of an additional 
band corresponding to a molar mass ~42 kDa in induced mixed membranes that is absent in uninduced mem-
branes. Western blotting using a His probe confirmed the 42 kDa protein is His-tagged and absent in uninduced 
cultures, suggesting that the 42 kDa protein is indeed IPTG-inducible VanS (Fig. 1B). VanS was purified using 
nickel affinity methods in the presence of n-dodecyl β -D-maltoside (DDM) detergent as described previously35,36. 
Figure 1C,D shows sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) and Western blot 
analysis of the purified protein which confirms an observed molar mass of approximately 42 kDa for the His-
tagged protein relative to the standards, in reasonable agreement with the predicted value taking into account 
the well-reported challenges of employing this relative technique for integral membrane proteins35. To confirm 
the molecular integrity and identity of purified VanS, electrospray ionisation mass spectrometry (ESI-MS) anal-
ysis revealed a mass of (45,775 ± 2) Da which matches closely to the predicted molecular mass for the recom-
binant intact protein of 45,765 Da (Fig. 2). Furthermore, N-terminal sequencing confirmed the presence of the 
expected N-MNSHM sequence; taken together with the evidence of an intact C-terminus (shown by Western 
detection of the C-terminal His6 tag), it is concluded that VanS is expressed as an intact membrane protein and 
that the observed lower mass of 42 kDa in SDS-PAGE is attributable to its anomalous migration behaviour by this 
approximate technique. To confirm that preparations of purified recombinant VanS are in an active conformation, 
autophosphorylation assays of kinase activity were undertaken as described previously and in Methods29,30,36. 
Autophosphorylation activity in the presence of ATP was demonstrable, even in the absence of added ligand/
signal, as shown to be the case for other active purified intact sensors (Fig. 3)30. Therefore, the purified VanS 
protein used in this study was active, suggesting no evident deleterious effects of the detergent used during the 
purification on subsequent activities of VanS including binding by exogenously-added ATP. We then explored 
the oligomeric state in aqueous solution of our preparation of VanS protein using the matrix-free techniques of 
sedimentation velocity and sedimentation equilibrium in the analytical ultracentrifuge.
Analytical ultracentrifugation. Sedimentation velocity in the analytical ultracentrifuge was performed at 
40000 rpm (~120 000 g) at 20.0 °C in HEPES buffer pH~7.9, I = 0.1, lacking detergent (removed by extensive dial-
ysis) and supplemented with 20% glycerol at a low loading concentration of 0.25 mg mL−1 to minimize the effects 
of hydrodynamic non-ideality. SEDFIT c(s) vs s analysis shows the majority of the material is overwhelmingly 
monomeric in aqueous solution. Figure 4 shows the SEDFIT c(s) vs s distribution (distribution of sedimentation 
coefficients). The plot shows the solution is highly monodisperse with the main component (96%) of sedimenta-
tion coefficient 0.9S and trace amounts (~4%) of a second component at 4.3S. To facilitate comparisons, Table 1 
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shows also the sedimentation coefficients normalized to standard solvent conditions (namely the density and 
viscosity of water at 20.0 °C).
The sedimentation coefficients will not only be influenced by molecular mass but also conformational (fric-
tional) effects. To identify/assign the molecular mass of the species present – and to confirm the main component 
is the VanS monomer − a further sedimentation equilibrium experiment was performed at a lower rotor speed 
of 25000 rpm (~48 000 g) and the minimum loading concentration of ~0.3 mg ml−1 to minimise the effects of 
thermodynamic non-ideality. Although not as resolving as sedimentation velocity, sedimentation equilibrium 
gives a direct measure of molecular weight (molar mass) unaffected by conformation, and for mixtures of more 
than one component, principally the weight average molar mass. We employ both the M* method of Creeth and 
Harding37 and the ‘Hinge point’ method32 implemented in the SEDFIT-MSTAR algorithm of Schuck, Harding 
and coworkers32. The results are shown in Fig. 5. Figure 5a shows the transformed concentration distribution c(r) 
in fringe displacement units as a function of radial position r, obtained from the sedimentation equilibrium inter-
ference fringes (inset) and Fig. 5b the corresponding plot of lnc(r) vs r2: the ~ linear nature of this plot is our first 
indicator of a highly monodisperse solution. The M* extrapolation (Fig. 5c) and hinge point estimation methods 
Figure 1. Purification and verification of His6-tagged intact VanS. (A) SDS-PAGE and (B) Western blotting 
of mixed membrane samples of E. coli host cells either uninduced (U) or induced (I) with 1 mM IPTG. (C) and 
(D) SDS-PAGE and Western blotting (respectively) of purified intact VanS protein ((C) 10 μ g in SDS-PAGE; 
(D) 1 and 5 μ g in Western blotting). SDS-PAGE employed 4% stacking and 12% resolving gels and proteins 
were visualised using Coomassie blue staining. Western blotting detected the presence of the C-terminal hexa-
histidine tag. Arrows denote the positions of monomeric VanS. (C) and (D) indicate the presence of multimeric 
VanS, even under denaturing conditions, as commonly observed during preparation of membrane proteins for 
SDS-PAGE (see Methods). M, molar mass markers.
Figure 2. Mass spectrometry of purified VanS. Analysis was carried out using ESI-MS. The m/z spectrum has 
been converted to a molecular mass profile using Maximum Entropy processing.
www.nature.com/scientificreports/
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(Fig. 5d) from this algorithm point to an overall weight average molar mass for the distribution, Mw = (47.7 ± 0.1) 
and (46.4 ± 0.1) kDa, respectively, in very close agreement with the expected value from mass spectroscopy of 
45774 Da (Fig. 2). The slightly higher value is possibly a reflection of the presence of a small amount of a higher 
Figure 3. Activity of purified intact VanS. Autophosphorylation assays were performed in buffer with 
no added detergent (DDM) and in triplicate using 60 pmoles (4 μ M) purified VanS incubated at 22.0 °C for 
20 min prior to addition of 50 μ M ATP (containing 3.75 μ Ci ɣ -33P ATP) for (A) 36 min at 37.0 °C and (B) 
30 min at 22.0 °C, after which time reactions were stopped by addition of stop buffer as described in Methods. 
Visualisation of phosphorylated proteins was by separation using SDS-PAGE and autoradiography. Membranes 
were exposed for (A) 8 days and (B) 5 days. The solid arrow denotes the position of monomeric VanS; the 
dashed arrow denotes multimeric VanS.
Figure 4. Sedimentation coefficient concentration distribution, c(s) vs s profile for VanS (Black profile) in 
HGN buffer pH~7.9, I = 0.1, at 20.0 °C at a loading concentration of 0.25 mg mL−1 (5.4 μM) (HGN buffer 
contains 20% glycerol). Rotor speed = 40000 rpm. Also shown is the profile for vancomycin 0.019 mg mL−1 
(12.8 μ M) (grey profiles) and a mixture of VanS and vancomycin (red profile) under the same conditions. An 
interaction between the two molecules is clearly evident.
www.nature.com/scientificreports/
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molecular weight component, as indicated by sedimentation velocity. The slight positive slope of the plot of ‘point’ 
average weight average molar mass Mw(r), as a function of radial position r, or the corresponding local con-
centration c(r) would also suggest that (Fig. 5d). So to explore this further, additional analysis was conducted 
using the MULTISIG algorithm of Gillis and coworkers33. This involves a multi exponential fit to the equilibrium 
distribution which is useful for assaying for the presence of discrete components of different molar mass. The 
results from this analysis (Fig. 6) also confirm that the VanS is almost completely monomeric with ~99% of 
material = 45.7 kDa and with < 1% of high molar mass material, M ~ 200 kDa, completely consistent with the 
SEDFIT-MSTAR result and the results from sedimentation velocity and mass spectroscopy. The close match 
between predicted and AUC-obtained molar masses of VanS suggests that detergent was largely removed during 
the extensive dialysis steps to a level that was hydrodynamically non-significant following protein purification.
Addition of vancomycin. Figure 4 also shows the SEDFIT c(s) vs s analysis of 0.25 mg.ml−1 (5.4 μ M) VanS 
in the presence of 19.1 μ g/ml (12.8 μ M) vancomycin. There is a significant change in the distribution in compari-
son with VanS by itself. The vancomycin (M = 1485 Da) control is currently below the lower limit of resolution of 
the sedimentation velocity method with current instrumentation (< 0.3S) but material (presumably aggregated 
material) is seen at 0.6 and 0.9S. However its effect on the VanS is to increase the sedimentation coefficient by over 
30% from (0.9 ± 0.1)S to (1.2 ± 0.2)S (Table 2). In addition, further higher sedimentation coefficient products 
sT,b (S) s20,w (S) % w/w
Main component 
(monomer) 0.9 ± 0.1 2.3 ± 0.1 96%
2nd peak 4.3 ± 0.2 10.9 ± 0.5 4%
Table 1. Sedimentation velocity on 0.25 mg/ml VanS in HGN buffer (10 mM, HEPES, 100 mM NaCl + 20% 
glycerol). Experiments conducted at 20.0 °C at a rotor speed of 40,000 rpm (check). 1S = 10−13 sec. sT,b: the value 
measured in the temperature and buffer (solvent), not normalized to standard conditions. s20,w: after correction/
normalization to standard solvent conditions – the density and viscosity of water at 20.0 °C.
Figure 5. Sedimentation Equilibrium SEDFIT-MSTAR output for analysis of VanS in HGN buffer pH~7.9, 
I = 0.1, (containing glycerol) at 7.0 °C at a loading concentration of 0.326 mg mL−1 in long (20 mm) path 
length cells. (a) concentration (fringe displacement units versus radial displacement from the centre of rotation, 
r (b) log concentration versus the square of the radial displacement (c) extrapolation of the M* function to the 
cell base to yield the “whole distribution” weight average molar mass Mw, = (47.5 ± 1.0) kDa; (d) plot of the 
point average molar mass (local molar mass) – obtained by taking the derivative of the data from plot (b) versus 
local concentration c(r) in the analytical ultracentrifuge cell. The value at the hinge point (where c(r) = the cell 
loading concentration, yields another estimate for the whole distribution Mw ~ (46.4 ± 1.0) kDa.
www.nature.com/scientificreports/
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appear at ~2.4S, 3.5S and 5.0S that are not present in the highly monomeric VanS by itself. This increase indicates 
an interaction of the vancomycin with the VanS. VanS-vancomycin interactions were also demonstrated previ-
ously in our laboratory and at the Diamond Light Source Ltd, by an alternative biophysical approach - circular 
dichroism (CD) measurements - and the data is shown in Fig 7. CD spectra obtained in the near-UV region 
(which interrogate changes in the tertiary structural conformation) show a clear change in the VanS difference 
spectrum in the presence of five-fold vancomycin, specifically in the 280–300 nm region contributed by Trp and 
Tyr residues, demonstrating an interaction between VanS and vancomycin (Fig. 7A). The difference spectrum for 
vancomycin alone is shown for comparison in Fig. 7B38.
With the sedimentation velocity plot (Fig. 4), the change in mass caused by the binding of the vancomycin is 
too small to lead to such a large (33%) change in the sedimentation coefficient by itself. The change is however 
commensurate with either a ligand induced dimerization and/or a ligand induced compaction of the monomer.
Discussion
Monomeric nature of VanS in the absence of ligand. In the absence of vancomycin, the hydrodynamic 
data are consistent with VanS being in the monomeric state (apart from the ~4% very high molecular mass com-
ponent). A single peak in a sedimentation velocity experiment is symptomatic of a single solute system. It could 
also in principle be symptomatic of a rapid monomer-dimer equilibrium39 – see for example ref. 40. However, the 
existence of a dimerization in the absence of ligand can be ruled out on the basis of the sedimentation equilibrium 
data. The weight average molar mass for the whole distribution Mw (from Fig. 5c and Fig. 6) is in exact agreement 
with the monomeric molar mass from mass spectrometry, confirming monomer. Further, if there was a mono-
mer-dimer equilibrium then the point average Mw(r) would significantly increase with concentration c(r). There 
is no evidence for this from Fig 5d.
We conclude therefore that purified intact VanS, in the absence of ligand, is predominantly monomeric under 
these conditions. VanS preparations and buffers were detergent free, ruling out the possibility that DDM might be 
responsible for VanS monomer conformation. We also note that the buffer used for the AUC experiments here is 
similar to that used to purify and maintain His-tagged VanS protein stocks, which were subsequently shown to be 
active under phosphorylation conditions (Fig. 3).
Figure 6. Sedimentation equilibrium Multi-Sig analysis of VanS in HGN buffer pH~7.9, I = 0.1, at 7.0 °C at 
a loading concentration of 0.3 mg mL−1 in long (20 mm) path length cells. The main (monomer) component 
of M = 45.7 kDa is seen (99%) with a trace (1%) amount of a large molecular weight product of M~200 kDa, 
possibly tetramer.
sT,b (S) s20,w (S) % w/w
Main component 1.2 ± 0.1 3.1 ± 0.2 73%
2nd peak 2.4 ± 0.2 6.2 ± 0.5 14%
3rd peak 3.5 ± 0.2 9.1 ± 0.6 6%
4th peak 5.0 ± 0.2 13.0 ± 0.8 7%
Table 2. Sedimentation velocity of 0.25 mg.mL−1 (5.4 μM) VanS in the presence of 19.1 μg/ml (12.8 μM) 
vancomycin and 20% glycerol (in HGN buffer). Experiments conducted at 20.0 °C at a rotor speed of 
40,000 rpm. 1S = 10−13 sec.
www.nature.com/scientificreports/
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Dilute solution conformation of VanS. It is possible to make an overall assessment of the conformation 
of VanS monomers, even though the protein is too large for high resolution NMR analysis and the protein has 
thus far resisted crystallisation. We can estimate the axial ratio of the equivalent hydrodynamic ellipsoid from the 
sedimentation coefficient and molar mass using the ELLIPS suite of software algorithms of Harding et al.34, based 
on reasonable values of the protein hydration δ (of 0.2 to 0.5 g/g). For an s20,w ~ 2.3S, Mw = 45775 g/mol: these 
data give a frictional ratio (f/f0) = 1.87 using the routine UNIVERSAL_PARAM. We can then evaluate the Perrin 
(P) universal shape function of a range of plausible values of the hydration δ from 0.2 to 0.5 g/g (Table 3). This 
yields an estimate for the axial ratio of the equivalent hydrodynamic (prolate) ellipsoid of revolution of ~(12 ± 2) 
as shown in Fig. 8. The monomer adopts an extended conformation. Such an extended structure could perhaps 
reflect the well documented structural architecture and modular nature of the membrane histidine kinase family 
in general which typically possess multiple domains that usually span the membrane resulting in spatial separa-
tion of some signal/ligand perception functions (occurring extracellularly or within/just inside the membrane) 
from catalytic activity functions (in the cytoplasm)41–43. Alternatively, the elongated shape may be a specific fea-
ture of VanS that is of functional importance (discussed further below).
Vancomycin binding and induced changes in VanS. The shift in sedimentation coefficient of the main 
peak in Fig. 4 on addition of vancomycin, is commensurate with two possible events – (i) a ligand-induced 
dimerization of the VanS with the additional appearance of 27% higher oligomerization product and/or (ii) a 
ligand-induced compaction of the monomer, with the appearance of 27% higher oligomerization product. We 
now consider each of these two possible interpretations of the data in turn.
Ligand-induced dimerization. Taking into account the extended conformation of the monomer species, a shift 
of 33% in s can be accounted for by a doubling of the molecular mass i.e. dimerization, allowing for a further 
small increase due to the vancomycin itself. The resulting s value (1.2S, or s20,w = 3.1S) would however be too 
small to be consistent with a side-by side dimerization and too large to be consistent with an end-to end, but 
would be consistent with an asymmetric binding somewhere between these extremes. Alternatively the s of the 
main peak, 1.2S could be the weighted average of a rapid monomer-dimer equilibrium, with the dimer itself of 
higher s and this would be more commensurate with a side-by-side process. In addition, there is ~27% of high 
molecular weight material (Table 2) consistent with ligand-induced higher oligomerization. This explanation for 
the increase in s would not be surprising since VanS is predicted to possess a dimerization/phosphoacceptor-type 
Figure 7. Circular dichroism analysis: molar ellipticity difference spectra of VanS, VanS in the presence 
of 5-fold vancomycin and vancomycin in the near-UV region at 20.0 °C. (A) Solid black line: VanS (9 μ M) 
following subtraction of any contributions from buffer and solvents. Dashed black line: VanS (9.0 μ M 
 = 0.41 mg mL−1) and vancomycin (45 μ M = 0.067 mg mL−1) (in phosphate-buffered saline) after subtraction 
of spectral contributions from vancomycin, buffer and solvents. (B) Solid black line: vancomycin (45 μ M) 
following subtraction of any contributions from buffer and solvents. Reaction mixes contained 10 mM HEPES, 
20% (v/v) glycerol, 100 mM NaCl and 0.05% n-dodecyl-β -D-maltoside, pH 7.9. Unsmoothed data shown.
f/fo Hydration δ P a/b
1.87 0.2 1.73 13.8
1.87 0.35 1.64 11.9
1.87 0.5 1.56 10.3
Table 3. The frictional ratio f/fo for VanS in HGN buffer, corresponding Perrin shape function P for a range 
of plausible hydration values, and the corresponding axial ratios, a/b of the equivalent prolate ellipsoid, 
from ELLIPS134.
www.nature.com/scientificreports/
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histidine kinase A domain (ncbi.nlm.nih.gov/Structure/cdd) and would be consistent with current mechanisms 
proposed for downstream signal transmission including the asymmetric piston shift model, scissoring or helical 
rotation of the two so-called p(eriplasmic) helices into an asymmetric complex or combinations of both of these 
(reviewed in ref. 41).
Ligand-induced compaction of monomer. Alternatively a 33% increase in the s value of the main (monomeric 
peak) could be equally explained by a compaction of the monomer. The increased s value for the same molecular 
mass would lead to a new frictional ratio f/fo = 1.39, and a P value of ~1.22, corresponding to a reduction in axial 
ratio on ligand binding from 12 to ~5.
To elucidate which of (i) or (ii), or if a combination of the two is responsible, will require further 
experimentation.
In previous studies of the diverse range of VanS sensor kinase family there has been much debate about the 
nature of the direct molecular ligands that activate them23. It was suggested previously that the VanS proteins of 
VanA, VanB and other types of vancomycin-resistant strains may all respond to different signals, evidenced in 
part by the distant relatedness between VanS sensors which share only 16% overall primary sequence identity. In 
the case of VanA-type strains of clinical enterococci investigated in the present study then, it has been demon-
strated here using a direct in vitro approach that vancomycin itself interacts directly with VanS. This is of course 
consistent with in vivo studies which showed that vancomycin induces resistance genes in VanA strains44–51. 
Direct interaction by the antibiotic itself was also reported for the distantly related VanSSC and VanSB sensors26–28. 
The distant relatedness between these sensors and to the VanSA sensor under study here indicates that the shared 
feature of these diverse sensors to interact with vancomycin must presumably be exerted through similarities 
at the tertiary level or alternatively through separate evolution of several different mechanisms to accomplish 
glycopeptide binding. Clearly future hydrodynamic and spectroscopic studies of these other sensors will help 
elucidate which of these possibilities might be correct. In any case, the in vitro approach used here employing 
purified protein indicates that binding of the antibiotic to VanS, at least to some extent, does not appear to require 
additional accessory factors. This study provides a platform for future studies on the elucidation of the strength 
and stoichiometry of this interaction and the effects of environmental conditions on the interaction, and the rela-
tion of the interaction to the oligomeric state, conformation and activity of this important two component system.
Methods
Gene cloning. The vanS gene of Enterococcus faecium BM4147/pFD225 possessing the VanA-type vancomy-
cin resistance operon (NCBI reference sequence WP_002305818.1) was cloned by Djalal Meziane-Cherif (Pasteur 
Institute) in pTTQ18His as a NdeI- and PstI-ended PCR-amplified fragment as described previously30,52 using 
standard cloning methods53 and the following primer pair:
FORWARD: 5′ -CGATCATG,AAT,TCG,CAT,ATG,GTT,ATA,AAA,TTG,AAA,AAT,AAA,AAA,AAC-3′ 
REVERSE: 5′ -CGATCCTGCAGC,GGA,CCT,CCT,TTT,ATC,AAC,CAA,GTC,TGG,C-3′ 
Cloned genes were confirmed by DNA sequencing. The resulting plasmid pTTQvanS possesses vanS posi-
tioned downstream of the IPTG-inducible tac promoter. Recombinant VanS possesses an additional MNSH 
sequence at the N-terminus and the His-tag sequence N-AAGGRGSHHHHHH-C at the C-terminus35.
Figure 8. Hydrodynamic shape of the VanS protein from ELLIPS1. The hydrodynamic data is consistent with 
an asymmetric structure of axial ratio ~(12 ± 2).
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Overexpression of recombinant His-tagged VanS. E. coli BL21 [DE3] harbouring pTTQvanS was cul-
tured aerobically at 37 °C in Luria Bertani (LB) medium containing 100 μ g/ml carbenicillin. Induction of VanS 
expression was achieved by addition of 1 mM isopropyl β -D-1-thiogalactoside (IPTG) to mid-exponential phase 
cultures followed by incubation for 3 h at 30 °C prior to cell harvesting30,52.
Preparation of total E. coli BL21 [DE3]/pTTQvanS membranes. Cell pellets were homogenised in 
10 mM Tris.HCl, 0.5 mM EDTA, 10% glycerol buffer and lysed using a Constant Systems cell disruptor. Lysates 
were centrifuged to remove cell debris (18,500 g for 45 min) and membranes prepared as described previously30,35.
Purification and final sample preparation for verification of intact VanS protein. Purification 
of intact his-tagged VanS was undertaken using total mixed membrane preparations of E. coli BL21 [DE3]/
pTTQvanS induced with IPTG as described previously30,35,52. Detergent-solubilised VanS was bound to bedded 
nickel-NTA resin columns (Qiagen) as described previously30,35. The resin was washed with 10 mM HEPES (pH 
7.9), 20 mM imidazole, 100 mM NaCl, 0.05% (w/v) n-dodecyl-β -D-maltoside, 2 mM β -mercaptoethanol, 20% 
(w/v) glycerol. VanS was eluted using the same buffer containing 200 mM imidazole. For SDS-PAGE, micellar 
protein was concentrated with Millipore Centricon filters of 100 MWCO. For AUC experiments, buffer exchange 
involved two rounds of extensive dialysis with using Spectra/Por® Float-A-Lyzer® G2 (3.5–5 kDa)) columns, 
using 10 mM HEPES (pH 7.9), 20% (w/v) glycerol, 100 mM NaCl with no added n-dodecyl-β -D-maltoside (HGN 
buffer). In preparation for in vitro autophosphorylation assays (which lacked added detergent), purified protein 
was prepared as described above except that (1) a final concentration of 0.025% DDM was used in all wash steps 
post-solubilisation; (2) there was no added NaCl in buffers; and (3) the elution buffer comprised 10 mM HEPES 
pH 7.9, 20% (v/v) glycerol and 0.025% DDM.
Electrospray ionization mass spectrometry (ESI-MS). Concentrated protein samples were diluted in 
40 mM ammonium acetate to produce samples of at least 5 μ M which were analysed by ESI-MS at the Astbury 
Centre for Structural Molecular Biology, University of Leeds, UK. Calibration of the m/z scale was achieved with 
a separate injection of horse heart myoglobin.
N-terminal sequencing. Purified proteins were separated on SDS-polyacrylamide gels, electroblotted onto 
PVDF membrane and stained with Coomassie Blue G-250. Excised proteins bands were sequenced by Edman 
degradation at Alta Bioscience Ltd, University of Birmingham, UK.
Western blotting. Proteins were separated by SDS-PAGE and electroblotted onto PVDF membranes for 
detection of the hexa-Histidine tag of expressed proteins using the INDIATM HisProbe-HRP (Perbio Science UK 
Ltd.) and Supersignal West Pico Chemiluminescent substrate (Pierce) detection system29. Chemiluminescence 
was detected using autoradiography or a gel documentation system.
Protein determination. Protein determinations were carried out using the BCA assay described in30 or by 
spectrophotometry at 280 nm. Extinction coefficients were calculated using contributions from Trp 5500 and Tyr 
1500 residues.
Autophosphorylation activity assays. Autophosphorylation assays were carried out at 22 °C and 37 °C in 
buffer with no added detergent (DDM) as described previously29,30 using 60 pmoles of purified VanS which were 
incubated for 20 minutes prior to initiation of autophosphorylation reactions. Reactions were initiated by addi-
tion of ATP (containing 185 kBq [γ -33P] ATP per 20 μ l reaction) to a final concentration of 50 μ M. Reactions were 
incubated for 36 min at 37.0 °C or 30 min at 22.0 °C before being stopped as described previously29,30. Reactions 
were loaded onto SDS-polyacrylamide gels to separate protein bands. Gels were dried by vacuum at 80 °C for 1 h 
and analysed by autoradiography.
Sources of vancomycin. Vancomycin was purchased from Sigma-Aldrich, UK.
Sedimentation velocity in the analytical ultracentrifuge. Sedimentation velocity experiments were 
performed in HGN buffer (10 mM HEPES (pH 7.9), 20% (w/v) glycerol, 100 mM NaCl buffer of den-
sity = 1.0655 g/ml, viscosity = 0.0209 Poise at 20.0 °C) using a Beckman (Palo Alto, CA, USA) Optima XL-I ana-
lytical ultracentrifuge equipped with Rayleigh interference optics and an automatic on-line data capture system. 
Conventional 12 mm double-sector epoxy cells with sapphire windows were loaded with 400 μ L (sample and 
reference solvent channels) and run at a rotor speed of 40000 rpm at a temperature of 20.0 °C. Concentration 
profiles and the movement of the sedimenting boundary in the analytical ultracentrifuge cell were recorded using 
the Rayleigh interference optical system and converted to concentration (in units of fringe displacement relative 
to the meniscus) versus radial position, r34. Data were analysed using the c(s) vs s model incorporated into the 
SEDFIT analytical algorithm of Dam & Schuck31. SEDFIT generates an apparent distribution of sedimentation 
coefficients in the form of c(s) versus s, where s is the sedimentation coefficient (in Svedberg units S = 10−13 sec). 
This data analysis was followed by the correction to standard solvent conditions - namely the density and viscosity 
of water at 20.0 °C - to yield s20,w using the algorithm SEDNTERP54, which also incorporates the partial specific 
volume (v) for VanS (v ~ 0.747 mL.g−1).
Sedimentation equilibrium in the analytical ultracentrifuge. Sedimentation equilibrium experi-
ments were also performed using the Beckman (Palo Alto, CA, USA) Optima XL-I analytical ultracentrifuge 
again using the Rayleigh interference optics and an automatic on-line data capture system, to record equilib-
rium concentration distribution profiles. The modified long (20 mm) optical path length double-sector titanium 
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cells with sapphire windows were selected and loaded with 130 μ L of solution (that had been dialysed against 
the HGN solvent to constant chemical potential55) and a matching amount of reference solvent dialysate in the 
appropriate channels. An equilibrium speed of 25000 rpm was employed. Because of the much longer duration of 
a sedimentation equilibrium experiment compared to sedimentation velocity samples were maintained at a low 
temperature of 7.0 °C and scans were taken once every hour until equilibrium had been reached after approx-
imately 96 hours. Optical records (Rayleigh interference profiles) of the relative concentration distribution of 
the solute at equilibrium were analysed to give the weight (mass) average apparent molar mass Mw,app using the 
SEDFIT-MSTAR algorithm32. This uses the M* function of Creeth and Harding37, together with the hinge point 
method (evaluation of the point or weight average molar mass at the radial position in the distribution where the 
local (total macromolecule) concentration c(r) = the initial loading concentration, c32. The use of long path length 
cells meant that low loading concentrations could be used to give a sufficient signal (~0.326 mg.mL−1) for records 
to be interpreted. At such low concentration, non-ideality effects (which tend to lead to underestimates of the 
molar mass) may be relatively small and we make the approximation that the apparent weight average molar mass 
Mw,app is equal to the true weight average molar mass Mw32. We also use MULTISIG33 to estimate the molar mass 
distribution56. This latter routine approximates the concentration distribution at sedimentation equilibrium by 
a 17-exponential fit: inversion of the exponent coefficients gives then an estimate of the distribution, the weight 
average molar mass and the polydispersity index (Mw/Mn), where Mn is the number average molar mass. The 
method is described in full detail in ref. 33.
Circular dichroism. Experiments were performed using a nitrogen-flushed instrument on the B23 
Synchotron Radiation CD Beamline at the Diamond Light Source, Oxfordshire, UK as described previously52.
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